Vaccine News and Research

Latest Vaccine News and Research

Do anti-nucleocapsid antibodies affect COVID-19 immune reactions?

Researchers have been investigating the potential for vaccines and treatments against the nucleocapsid protein of SARS-CoV-2.

15 Mar 2022

SARS-CoV-2 in diabetes pathogenesis

Researchers reviewed the causes of diabetes mellitus, focusing on respiratory viruses, including influenza virus and SARS-CoV-2.

15 Mar 2022

Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

Researchers identified and validated multiple linear B-cell epitopes in the SARS-CoV-2 proteomes conserved in humans coronaviruses.

15 Mar 2022

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

RSV is a leading cause of severe acute lower respiratory tract infections (LRTIs) among infants globally, and a prominent contributor to common non-severe infections that account for high volumes of antibiotic consumption.

14 Mar 2022

Researchers develop a mathematical model to predict COVID-19 vaccine efficacy

Researchers at The University of Queensland have developed a mathematical model that can predict the efficacy of COVID-19 vaccines, potentially speeding-up the development of new vaccines.

14 Mar 2022

Researchers find unusual way of stabilizing cancer-suppressing protein

The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however, that it breaks down rapidly in the cell. Researchers at Karolinska Institutet in Sweden have now found an unusual way of stabilizing the protein and making it more potent.

14 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

Malaria drug could help treat chemotherapy-resistant head and neck cancers

A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.

14 Mar 2022

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

14 Mar 2022

UK Government to remove all COVID-19 international travel restrictions

The government will remove the remaining restrictions on international travel for all passengers ahead of the Easter holidays, the Transport Secretary announced today (14 March 2022).

14 Mar 2022

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

A new study determined the humoral responses against SARS-CoV-2 in vaccinated hospital workers.

14 Mar 2022

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

A new study assessed the neutralization induced by subunit vaccine boosters specific for the SARS-CoV-2 Omicron variant of concern.

14 Mar 2022

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Researchers analyze the available scientific evidence supporting vitamin D as a neuroprotective agent against the neurological sequelae of COVID-19.

14 Mar 2022

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Researchers assessed the impact of demographic variability on the Pfizer/BioNTech BNT162b2 vaccine-induced serological immunity against SARS-CoV-2 variants of concern and variants of interest.

14 Mar 2022

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Scientists simulate different scenarios using facemasks through a computational Monte Carlo simulation model.

14 Mar 2022

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

A recent study assessed the reactogenicity and immunogenicity induced by SARS-CoV-2 vaccines in adolescent individuals.

14 Mar 2022

New approach to send ‘friendly’ nano-particles into the body shows promising results

A new approach to send ‘friendly’ nano-particles into a patient’s blood stream has shown promising results by modifying the surface of these potential drug, vaccine or cancer treatment delivery objects to encourage the best result.

14 Mar 2022

Survey: About 16% of couples are discordant about COVID-19 vaccination

A small but significant portion of couples contain one partner who is vaccinated against COVID-19 and another partner who is not, a Washington State University survey has found.

11 Mar 2022

Modifying red blood cells to create a promising new vehicle for vaccine delivery

Physicists, chemists and immunologists at McMaster University have teamed up to modify red blood cells to transport viral agents which can safely trigger the immune system to protect the body against SARS-CoV-2, creating a promising new vehicle for vaccine delivery.

11 Mar 2022

Mice study shows how to improve long-term effectiveness of TB vaccine

Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research Institute report this week in the Journal of Immunology.

11 Mar 2022

Vaccine News and Research

Latest Vaccine News and Research

Do anti-nucleocapsid antibodies affect COVID-19 immune reactions?

SARS-CoV-2 in diabetes pathogenesis

Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

Researchers develop a mathematical model to predict COVID-19 vaccine efficacy

Researchers find unusual way of stabilizing cancer-suppressing protein

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

Malaria drug could help treat chemotherapy-resistant head and neck cancers

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

UK Government to remove all COVID-19 international travel restrictions

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

New approach to send ‘friendly’ nano-particles into the body shows promising results

Survey: About 16% of couples are discordant about COVID-19 vaccination

Modifying red blood cells to create a promising new vehicle for vaccine delivery

Mice study shows how to improve long-term effectiveness of TB vaccine

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in